Compare Wockhardt with TTK HEALTHCARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs TTK HEALTHCARE - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT TTK HEALTHCARE WOCKHARDT/
TTK HEALTHCARE
 
P/E (TTM) x -13.9 24.5 - View Chart
P/BV x 1.1 1.7 64.4% View Chart
Dividend Yield % 0.0 0.9 0.4%  

Financials

 WOCKHARDT   TTK HEALTHCARE
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
TTK HEALTHCARE
Mar-19
WOCKHARDT/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs1,0121,215 83.3%   
Low Rs532610 87.1%   
Sales per share (Unadj.) Rs355.9444.4 80.1%  
Earnings per share (Unadj.) Rs-60.317.2 -349.5%  
Cash flow per share (Unadj.) Rs-46.827.6 -169.2%  
Dividends per share (Unadj.) Rs0.015.00 0.2%  
Dividend yield (eoy) %00.5 0.2%  
Book value per share (Unadj.) Rs257.8177.9 144.9%  
Shares outstanding (eoy) m110.6314.13 782.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.22.1 105.6%   
Avg P/E ratio x-12.852.9 -24.2%  
P/CF ratio (eoy) x-16.533.0 -50.0%  
Price / Book Value ratio x3.05.1 58.4%  
Dividend payout %029.0 -0.1%   
Avg Mkt Cap Rs m85,37912,894 662.1%   
No. of employees `0006.32.3 270.5%   
Total wages/salary Rs m9,3711,307 717.0%   
Avg. sales/employee Rs Th6,295.02,715.7 231.8%   
Avg. wages/employee Rs Th1,498.3565.3 265.0%   
Avg. net profit/employee Rs Th-1,066.3105.4 -1,011.6%   
INCOME DATA
Net Sales Rs m39,3696,279 627.0%  
Other income Rs m1,20278 1,551.4%   
Total revenues Rs m40,5716,356 638.3%   
Gross profit Rs m18496 3.7%  
Depreciation Rs m1,495147 1,019.3%   
Interest Rs m2,55534 7,558.9%   
Profit before tax Rs m-2,830393 -720.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m257149 172.6%   
Profit after tax Rs m-6,669244 -2,736.4%  
Gross profit margin %07.9 0.6%  
Effective tax rate %-9.137.9 -23.9%   
Net profit margin %-16.93.9 -436.4%  
BALANCE SHEET DATA
Current assets Rs m33,7962,717 1,243.8%   
Current liabilities Rs m26,9171,571 1,713.6%   
Net working cap to sales %17.518.3 95.7%  
Current ratio x1.31.7 72.6%  
Inventory Days Days7932 246.7%  
Debtors Days Days8947 191.3%  
Net fixed assets Rs m39,664991 4,002.4%   
Share capital Rs m553141 391.5%   
"Free" reserves Rs m27,9682,373 1,178.6%   
Net worth Rs m28,5222,514 1,134.4%   
Long term debt Rs m21,7313 639,150.0%   
Total assets Rs m81,6204,158 1,962.9%  
Interest coverage x-0.112.6 -0.9%   
Debt to equity ratio x0.80 56,344.0%  
Sales to assets ratio x0.51.5 31.9%   
Return on assets %-5.06.7 -75.5%  
Return on equity %-23.49.7 -241.2%  
Return on capital %-7.716.9 -45.3%  
Exports to sales %03.6 0.0%   
Imports to sales %00.5 0.0%   
Exports (fob) Rs mNA225 0.0%   
Imports (cif) Rs mNA31 0.0%   
Fx inflow Rs m9,807225 4,354.8%   
Fx outflow Rs m1,78971 2,515.3%   
Net fx Rs m8,019154 5,203.8%   
CASH FLOW
From Operations Rs m684173 395.4%  
From Investments Rs m6,30297 6,531.0%  
From Financial Activity Rs m-7,695-307 2,504.0%  
Net Cashflow Rs m-664-38 1,761.3%  

Share Holding

Indian Promoters % 74.5 65.4 113.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 3.7 62.2%  
FIIs % 7.7 5.2 148.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 25.8 59.7%  
Shareholders   67,757 12,723 532.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   DIVIS LABORATORIES  GLENMARK PHARMA  SUN PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare WOCKHARDT With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 271 Points Higher; Capital Goods and Realty Stocks Rally(Closing)

Indian share markets witnessed buying interest during closing hours today and ended higher. Benchmark indices regained momentum amid huge buying seen in capital goods and realty stocks.

Related Views on News

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

WOCKHARDT Announces Quarterly Results (4QFY19); Net Profit Up 90.8% (Quarterly Result Update)

May 7, 2019 | Updated on May 7, 2019

For the quarter ended March 2019, WOCKHARDT has posted a net profit of Rs 139 m (up 90.8% YoY). Sales on the other hand came in at Rs 10 bn (down 3.8% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Jan 23, 2020 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS